Randomization
melanoma
DISEASE, MELANOMA
Following written consent and completion of the baseline survey, participants were randomized 1:1 to the intervention or control arm. Randomization was stratified by age (<50, 50+ years old), gender (male, female), disease stage (I, II, III/IV, unknown), and years since first melanoma diagnosis (< 2 years, 2–5 years, 6+ years). Randomization was implemented within REDCap by the study coordinator. Everyone except the study coordinator and statistician were blinded to the randomization. Participants were not informed of their randomized group or provided specific information about what to expect from the mobile app.